Loss of IL-10 secretion by regulatory B lymphocytes in multiple sclerosis patients by Michel, Laure et al.
Loss of IL-10 secretion by regulatory B lymphocytes in
multiple sclerosis patients
Laure Michel, Nicolas Degauque, Alexandra Garcia, Marion Salou, Annie
Ngono, Jean-Paul Soulillou, David Laplaud, Sophie Brouard
To cite this version:
Laure Michel, Nicolas Degauque, Alexandra Garcia, Marion Salou, Annie Ngono, et al.. Loss
of IL-10 secretion by regulatory B lymphocytes in multiple sclerosis patients. 6th european
workshop on immune-mediated inflammatory diseases, Nice, France. BioMed Central, 9 (Suppl
2), pp.P25, 2011. <inserm-00643972>
HAL Id: inserm-00643972
http://www.hal.inserm.fr/inserm-00643972
Submitted on 23 Nov 2011
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
POSTER PRESENTATION Open Access
Loss of IL-10 secretion by regulatory B
lymphocytes in multiple sclerosis patients
Laure Michel1,2*, Nicolas Degauque1, Alexandra Garcia1, Marion Salou1, Annie Elong Ngono1, Jean-Paul Soulillou1,
David Laplaud1,2, Sophie Brouard1
From 6th European Workshop on Immune-Mediated Inflammatory Diseases
Nice, France. 23-25 November 2011
Background
Recently, an alternative role of B cells has emerged. Regu-
latory B cells have been shown to down-regulate immune
responses in mice and humans. These cells control disease
progression in several models of human autoimmune
diseases, including a model of Multiple Sclerosis (MS).
Their regulatory function mostly relies on their capacity to
produce IL-10.
Objectives
Our aim was to explore the frequency, the phenotype and
the functional properties of regulatory B cells in MS
patients compared to Healthy Volunteers (HV).
Methods
All patients suffered from MS and had not received
immune drugs since at least 6 months. The frequency and
the phenotype of B cell subsets have been analysed using
different specific markers: CD19+CD27+ memory B cells,
CD19+CD38dimCD24dim mature naïve B cells and CD19+
CD24highCD38high transitional B cells. Their capacity to
secrete IL-10 was analysed in vitro 48 hours after stimula-
tion by CD40 ligand and CpG ODN.
Results
Thirty-eight MS patients (mean age: 41.55±12.8 yrs) and
21 HV (mean age: 35.4±13.4 yrs, NS) have been
included. The patients had different MS forms: Clini-
cally Isolated Syndrome (n=5), Relapsing-Remitting
(n=23), Secondary Progressive (n=4) and Primary Pro-
gressive (n=6).
No significant difference was found for the frequency
of the different B cell subsets in the different subgroups
of patients. Particularly, MS patients harbor the same
number (in frequency and absolute value) of CD19+
CD24highCD38high transitional B cells. However, the fre-
quency of IL-10 secreting B cells was significantly
decreased in MS patients (0.9±0.5%, n=9) compared to
HV (2±0.95%, n=10, p<0.05, Mann Whitney test).
Discussion/perspectives
MS patients display the same frequency of CD19+
CD24highCD38high transitional B cells, described as hav-
ing regulatory properties. Nevertheless, B cells of MS
patients present a significant decreased secretion of IL-
10, supporting a defect in the B cells regulatory property.
If confirmed, these results could have a considerable
impact for the development of new therapeutic strategies.
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